Good Start Genetics Aims to Expand Reach Beyond Fertility Clinics; Build Clinical NGS Company
By Monica Hager
February 13, 2013

Ten months after launching its sequencing-based carrier screening test, Good Start Genetics is looking to eventually market the test not only to fertility clinics, but Ob/Gyn practices, as well as move into other areas of reproductive health and build a "fully integrated clinical next-gen sequencing company," CEO Don Hardison said this week at the BIO CEO conference in New York.